Indication

Opioid-induced respiratory depression

Opioid-induced respiratory depression is a potentially fatal adverse effect and medical emergency characterized by significant central nervous system and ventilatory suppression following exposure to opioid agonists. Read more about Opioid-induced respiratory depression

57 drugs 49 manufacturers

Advertisement

Drugs that treat it

Common Opioid-induced respiratory depression therapies.

Showing 55–57 of 57 drugs

NALOXONE HCL

OPIOID ANTAGONISTS·OPIOID OVERDOSE·+2
LIFESTAR-NOVAPL
Filter & compare in the drug finder →Opens the drug finder with Opioid-induced respiratory depression preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Opioid-induced respiratory depression.

Opioid-induced respiratory depression is a potentially fatal adverse effect and medical emergency characterized by significant central nervous system and ventilatory suppression following exposure to opioid agonists.

Pathophysiologically, it occurs when opioids activate mu-opioid receptors within respiratory control networks of the brainstem, specifically dampening neural rhythmogenesis in the pre-Bötzinger complex and blunting central and peripheral chemoreceptor sensitivity to rising hypercapnia and hypoxia.

Clinically, affected patients exhibit hypoventilation characterized by markedly decreased respiratory rate, shallow breathing, periodic apnea, and progressive central nervous system sedation, which leads to severe hypoxemia, respiratory acidosis, and potential cardiac arrest if left uncorrected.

Personalize your experience

Follow Opioid-induced respiratory depression and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it